Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

Posts tagged ‘Science Blogging’

For those readers who would like to access Biotech Strategy Blog on their Kindle, this is a quick post to let you know it is now available on the Amazon Kindle Store for $0.99/month.  You can also continue to read it for free on the web.

Biotech-Strategy-Blog-Amazon-Kindle-StoreOf course, after Amazon takes its cut there is a (very) small royalty fee that ends up coming my way, so I have vested self-interest in promoting this.  However, it’s not something I anticipate getting rich from!

In a world of multi-channel marketing, it is good to try out new ideas that may make it easier for people to access content and information.

Twitter is a fascinating source of news and current affairs that allows you to share in events from a distance.  I was, therefore, fascinated to see Tweets from a recent healthcare meeting in which CNN discussed how they are having to compete with bloggers.

CNN claimed that this was due to bloggers violating embargoes on the publication of scientific data.  As a science blogger, I questioned whether this naked assertion was correct?

Using Storify, I captured the Tweets and looked into more detail as to “Who cheats and breaks science new reporting embargoes?”

You can read this on Storify, or in the embedded post below.

error: Content is protected !!